AusPAR: Keytruda

Australian Public Assessment Report

AusPAR

AusPAR: Keytruda [PDF, 2.45 MB]

AusPAR: Keytruda [Word, 5.65 MB]

AusPAR Attachment 1: Product Information for Keytruda [PDF, 2.39 MB]

AusPAR Attachment 1: Product Information for Keytruda [Word, 2.62 MB]

Device/Product Name

Keytruda

Active ingredients

Pembrolizumab

AusPAR Date

8 May 2023

Published

16 May 2023

Submission Number

PM-2021-04831-1-4

Submission Type

Extension of indications

Decision

Approved